Delivery Order SPE2DB20D3103-SPE2DB24FP3H0
Award Date
6/26/24
Potential Completion Date
6/27/24
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Isentress 400 mg tablets, a medication used for the treatment of HIV infection. The contract has a ceiling value of $5,031.90 and a completion date of March 26, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,747.62 fixed-price delivery order is for Isentress 400 mg tablets, a medication used to treat HIV infection. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award, valued at $4,306.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Isentress 400 mg tablets, a medication used in the treatment of HIV/AIDS. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,394.57, is for the delivery of Isentress 400 mg tablets, a medication used in the treatment of HIV/AIDS. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
This federal contract award, valued at $6,871.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Isentress 400 mg tablets, a medication used in the treatment of HIV, and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,978.92 firm fixed-price contract is for the supply of Isentress 400 mg tablets, a medication used in the treatment of HIV/AIDS. The contract has a completion date of May 17, 2023 and was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Isentress 400 mg tablets. The contract has a ceiling value of $7,768.72 and runs through April 14, 2025. It is a firm-fixed-price contract without any set-aside designation, indicating open competition. The contract is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Isentress 400 mg tablets, a medication used in the treatment of HIV. The contract has a ceiling value of $4,274.85 and a period of performance through May 6, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,218.31, is for the delivery of Isentress 400 mg tablets to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,896.72 firm-fixed-price delivery order is for the supply of ISENTRESS 400 MG TABLET 60S, a medication used in the treatment of HIV/AIDS. The contract has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...